A Rare Approval. FDA OKs Pediatric Cancer Drug
Morrow, T.
Managed Care 24(10): 42-43
2015
ISSN/ISBN: 1062-3388 PMID: 26665714 Document Number: 682173
Document emailed within 1 workday
Related Documents
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19Anderson, L.F. 1989: Cancer and AIDS groups push for changes in drug approval process Journal of the National Cancer Institute 81(11): 829-831
Astrup, K.G.; Riis, P. 1995: Drug approval. Orientation from the drug department of the National Board of Health and Welfare and the scientific-ethical committee system Ugeskrift for Laeger 157(46): 6442-6443
Gifford, R.W. 1980: The FDA new drug approval process Connecticut Medicine 44(5): 309-311
Stribling, J.H. 1992: What's holding up animal drug approval? Journal of the American Veterinary Medical Association 200(12): 1806-1808
Otsuka, Y. 2012: Drug approval lag in Japan and drugs for children No to Hattatsu 44(1): 2
1991: Pre-approval inspections/investigations. Food and Drug Administration Journal of parenteral science and technology: a publication of the Parenteral Drug Association 45(1): 56-66
1993: FDA issues regulations on accelerated drug-approval process Clinical Pharmacy 12(4): 253-254
Kahn, L.G. 1998: Research resources for aquaculture drug development and approval Veterinary and Human Toxicology 40(Suppl 2): 41-43
Wolfe, S.M. 2014: Does $760 m a year of industry funding affect the FDA's drug approval process? Bmj 349: G5012
de Graeff PA; Hoppe 1996: The use of ambulatory blood pressure monitoring to evaluate antihypertensive drugs for drug approval Blood Pressure Monitoring 1(3): 313-315
Fredd, S.B. 1990: The OTC drug approval process. The ACG Committee on FDA-Related Matters. American College of Gastroenterology American Journal of Gastroenterology 85(1): 12-14
Koering, S.M. 2002: A cancer program's seal of approval Journal of Ahima 73(1): 40-44
Browne, T.R. 1993: Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods Epilepsy Research. Suppl 10: 31-44
Robinson, L.A. 1979: Pediatric drug information: drug therapy in nursing mothers Pediatric Nursing 5(6): 68-69; 84
Cintrón-Ortiz, C.J.; González de Pijem, L. 1990: Thyroid cancer in pediatric patients: the University Pediatric Hospital experience Boletin de la Asociacion Medica de Puerto Rico 82(5): 204-206
Török, S.; Borgulya, G.; Schuler, D. 2001: Changes of the incidence and survival in pediatric malignant tumors between 1988-1997, according to the data of the Hungarian Pediatric Cancer Registry Orvosi Hetilap 142(23): 1211-1215
Carroll, P.B.; Rilo, H.; Reyes, J.; Alejandro, R.; Zeng, Y.; Ricordi, C.; Tzakis, A.; Shapiro, R.; Starzl, T.E. 1991: FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication Transplantation Proceedings 23(6): 3171-3172
Kocher, N.J.; Loloi, J.; Warrick, J.; Burns, A.S.; Decter, R.M. 2019: Ectopic ACTH-secreting neuroendocrine tumor: a rare etiology of a pediatric solid renal mass Canadian Journal of Urology 26(5): 9956-9959
Souteyrand, P.; d'Incan, M.; Parent, S. 2000: Misleading or rare cutaneous drug reactions La Revue du Praticien 50(12): 1329-1333